H1 secures $40M from CVS, proving SaaS startups can still attract investment - BERITAJA
H1 secures $40M from CVS, proving SaaS startups can still attract investment - BERITAJA is one of the most discussed topics today. In this article, you will find a clear explanation, key facts, and the latest updates related to this topic, presented in a concise and easy-to-understand way. Read more news on Beritaja.
Image Credits:H111:08 AM PDT · May 28, 2026
It’s nary concealed that pre-AI era startups are mostly getting small emotion from investors now.
Ariel Katz, co-founder and CEO of a nine-year-old healthcare information level H1, argues that not each SaaS companies should beryllium painted pinch the aforesaid wide brush.
“If you’re a workflow SaaS company, you could vibe codification that,” he told TechCrunch. What AI cannot easy replicate, according to Katz, is simply a institution that is simply a information supplier astatine its core.
That’s a self-serving viewpoint — H1’s full business is built connected trading elaborate accusation about doctors to pharma companies, infirmary systems, and wellness insurers — but it doesn’t mean he is wrong.
“I don’t interest about Claude ever doing what we do,” Katz said, referring to Anthropic’s celebrated AI model. He thinks that the information H1 collects connected physicians globally could really beryllium truthful valuable to AI exemplary makers that they are much apt to go customers than competitors.
CVS Health Ventures, the firm task superior limb of the CVS/Aetna wellness giant, must work together that H1 is successful nary threat of becoming a unfortunate of the “SaaSocalypse.” The investor conscionable led a $40 cardinal information into H1.
H1 wasn’t looking to raise capital, Katz said. The startup turned rate travel and EBITDA profitable past twelvemonth and is forecasting to turn complete 40% this year. But the business pinch 1 of the largest healthcare companies successful the world was difficult to refuse, Katz said.
Despite the beardown financial fundamentals, companies for illustration H1 aren’t breathtaking for accepted VCs who are presently consumed pinch backing AI startups astatine skyrocketing valuations.
H1 was past weighted astatine $750 million erstwhile it raised $100 cardinal successful backing led by Altimeter Capital astatine the tallness of the Covid-era tech bubble successful November of 2021.
Like different companies that secured superior conscionable earlier valuations plummeted successful 2022, H1 has focused connected becoming profitable. The startup has besides grown done acquiring smaller competitors and complementary businesses.
When you acquisition done links successful our articles, we whitethorn gain a mini commission. This doesn’t impact our editorial independence.
Marina Temkin is simply a task superior and startups newsman astatine TechCrunch. Prior to joining TechCrunch, she wrote about VC for PitchBook and Venture Capital Journal. Earlier successful her career, Marina was a financial expert and earned a CFA charterholder designation.
You could interaction aliases verify outreach from Marina by emailing marina.temkin@beritaja.com aliases via encrypted connection astatine +1 347-683-3909 connected Signal.
Subscribe
This article discusses H1 secures $40M from CVS, proving SaaS startups can still attract investment - BERITAJA in detail, including key facts, recent developments, and important insights that readers are actively searching for online.